技术指标
指标
数值
方向
MACD(12,26,9)
-0.053
中性
RSI(14)
62.549
中性
STOCH(KDJ)(9,3,3)
53.605
买入
ATR(14)
0.290
高波动
CCI(14)
203.515
超买
Williams %R
20.686
买入
TRIX(12,20)
-0.352
卖出
StochRSI(14)
100.000
买入
搜索
WGRX
WGRX添加自选
3.520USD
0.0000.00%
收盘 07-21 16:00（美东）报价延迟15分钟
9.00M总市值
亏损市盈率 TTM
关键数据
--今开
0.000最高
0.00成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
22.98%换手率
3.520昨收
0.000最低
0.00成交额
亏损市盈率静
-0.56市净率
0.00%股息率 TTM
-173.68%ROA
128.00052周最高
27.39量比
-6.86M净利润
2.39M总股本
-0.8760每股收益TTM
--Beta
-927.67%ROE
3.04052周最低
39.48%振幅
-11.97%毛利率
9.00M总市值
-1.06回报/风险
11.83%风险率
TradingKey WGRX股票评分
单位: USD 更新时间: 2026-07-21操作建议
Wellgistics Health Inc当前公司基本面数据相对谨慎，增长潜力稳定。当前估值合理，在医疗设备与耗材行业排名147/203位。机构持股占比非常高，中期看，股价处于上升通道。近一个月，市场表现较强，但基本面和技术面综合得分较低，较强的走势没有得到基本面和技术面印证。目前股价在压力位和支撑位之间，可以做区间波段操作。
WGRX评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
WGRX亮点
亮点风险
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
业绩增长期
公司处于发展阶段，最新年度总收入23.34M美元
利润高增长
公司净利润处于行业前列，最新年度总收入23.34M美元
估值低估
公司最新PE估值-4.02，处于3年历史低位
史蒂文·科恩持仓
明星投资者史蒂文·科恩持仓，最新持仓市值15.25
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
WGRX新闻
即将为您带来更多新闻，敬请期待。。。
技术指标
移动平均线
指标
数值
方向
MA5
2.876
买入
MA10
2.912
买入
MA20
2.958
买入
MA50
2.636
买入
MA100
1.388
买入
MA200
0.942
买入
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
WGRX简介
Wellgistics Health, Inc. is a holding company, which conducts business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It focuses on specialty medications and a community-based model offering home delivery services to patients. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows for clinical services to be connected to the Company’s health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, improve prescription price transparency, and provide additional concierge services. Its products include Kyzatrex and Semaglutide and Tirzepatide.
公司代码WGRX
公司Wellgistics Health Inc
CEOMr. Brian Norton
网址https://wellgisticshealth.com/
公司股东
相关品种
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%
